Trial Search Results

Effects of Dietary Antioxidants on Cardiovascular Risk Factors

The aim of the Antioxidant Study was to compare the efficacy of foods naturally rich in antioxidants with that of antioxidants in a pill form on markers of inflammation and plasma cholesterol in healthy adults at risk of cardiovascular disease.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Christopher Gardner

Collaborator: National Center for Complementary and Integrative Health (NCCIH)

Stanford Investigator(s):

Intervention(s):

  • Behavioral: Antioxidant diet
  • Dietary Supplement: Antioxidant supplement
  • Dietary Supplement: Placebo

Phase:

N/A

Eligibility


Inclusion Criteria:Overweight/obesity; high LDL cholesterol, pre-hypertension.

Exclusion Criteria:1. Daily intake of > 5 servings of vegetables and fruits 2. Fasting
blood glucose >140 mg/dL 3. BMI >40 4. Liver or renal disease; Atherosclerosis (e.g., CAD,
PAD); Malignant neoplasm; Ongoing infection; Inflammatory disease 5.Currently taking the
following medications: Anti-inflammatory drugs Lipid lowering drugs Anti-hypertensive drugs
Calcium containing drugs Drugs known to affect blood coagulation Drugs known to affect
antioxidant status 6. Pregnant or lactating 7. Inability to communicate effectively with
study staff

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Antonella Dewell
6507368577
Not Recruiting